Indirect action of tumor necrosis factor-alpha in liver injury during the CD8+ T cell response to an adeno-associated virus vector in mice.
Indirect action of tumor necrosis factor-alpha in liver injury during the CD8+ T cell response to an adeno-associated virus vector in mice.
复制标题
DOI:
10.1002/hep.22869
复制
发表时间:
2009-06
期刊:
影响因子:
13.5
通讯作者:
Crispe, Ian Nicholas
中科院分区:
文献类型:
--
作者:
Giannandrea, Matthew;Pierce, Robert H.;Crispe, Ian Nicholas
CD8+ T-cells can cause hepatocellular injury by two distinct mechanisms. In addition to their direct cytotoxic effect, there is also collateral liver injury, which occurs when cells are killed in an antigen independent manner. While immune effector cytokines Interferon-gamma (IFNγ) and Tumor Necrosis Factor-alpha (TNFα) have both been implicated in various forms of hepatitis, their respective roles in direct and/or collateral liver damage remains unclear. In order to investigate these elements of liver injury, we have developed a new experimental model of CD8+ T-cell mediated hepatitis based on an Adeno-Associated Virus-based gene therapy vector. This vector is used to deliver antigen to hepatocytes, and CD8+ T-cells specific for the vector-encoded transgene are adoptively transferred to produce liver immunopathology. In this experimental model, CD8+ T-cell IFNγ acts on Kupffer cells, inducing TNFα secretion and liver injury. Both IFNγ and TNFα are important in this injury process, but TNFα acts as an autocrine amplifier of Kupffer cell function, rather than as a direct effector of hepatocellular damage. Conclusion: TNFα indirectly promotes liver damage, and is not a direct hepatotoxic agent. IFNγ also indirectly contributes to liver injury via Kupffer cell activation while, in parallel, directly promoting hepatitis via induction of hepatocyte MHC class I. In principle, it may be possible to ameliorate this immunopathologic indirect mechanism by developing therapies that target Kupffer cells, without impairing CD8+ T-cell mediated antiviral immunity. This would have great therapeutic potential in chronic viral hepatitis.
登录
查看更多内容
影响因子:
6
作者:
Polakos, NK;Cornejo, JC;Pierce, RH
通讯作者:
Pierce, RH
影响因子:
13.5
作者:
Griffon, B;Cillard, J;Sergent, O
通讯作者:
Sergent, O
影响因子:
15.3
作者:
LEHMANN, V;FREUDENBERG, MA;GALANOS, C
通讯作者:
GALANOS, C
DOI:
10.1084/jem.20061287
发表时间:
2007-03-19
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Dunn C;Brunetto M;Reynolds G;Christophides T;Kennedy PT;Lampertico P;Das A;Lopes AR;Borrow P;Williams K;Humphreys E;Afford S;Adams DH;Bertoletti A;Maini MK
通讯作者:
Maini MK
DOI:
10.1152/ajpgi.00422.2005
发表时间:
2006-04-01
影响因子:
4.5
作者:
Schwabe, RF;Brenner, DA
通讯作者:
Brenner, DA